Literature DB >> 8302347

Riluzole for the treatment of amyotrophic lateral sclerosis--too soon to tell?

L P Rowland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8302347     DOI： 10.1056/NEJM199403033300911

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  Cost effectiveness of riluzole in amyotrophic lateral sclerosis. Italian Cooperative Group for the Study of Meta-Analysis and the Osservatorio SIFO sui Farmaci.

Authors:  A Messori; S Trippoli; P Becagli; G Zaccara
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

Review 3.  Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.

Authors:  H M Bryson; B Fulton; P Benfield
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 4.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Authors:  Robert G Miller; J D Mitchell; Dan H Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.